Experience

Gesund.ai

• United States
• Hospitals and Health Care
• 1 - 100 Employee

• Vice President of Business Development

  • Nov 2022 - 1 year 2 months

  San Francisco Bay Area Gesund.ai is making responsible medical AI an operational reality for AI developers in the life sciences industry and healthcare. Medical AI needs to transition to production environments and more adoption in the clinic. Gesund was designed to make all steps from R(esearch) to D(evelopment) and C(ommercialization) of medical AI more transparent, efficient, and better. I drive commercial growth, work with government agencies to shape future guardrails for medical AI, and help recruit and… Show more Gesund.ai is making responsible medical AI an operational reality for AI developers in the life sciences industry and healthcare. Medical AI needs to transition to production environments and more adoption in the clinic. Gesund was designed to make all steps from R(esearch) to D(evelopment) and C(ommercialization) of medical AI more transparent, efficient, and better. I drive commercial growth, work with government agencies to shape future guardrails for medical AI, and help recruit and lead teams, all in partnership with the CEO and VP of Engineering. Show less



Caresyntax

• United States
• Hospitals and Health Care
• 100 - 200 Employee

• VP, Head of Data and AI

  • Aug 2021 - Aug 2022

  San Francisco Bay Area Recruited to advance Caresyntax's transition from innovation in IoT to SaaS to RWD/RWE. Reported to CEO. P&L responsibility. Joined portfolio management committee. Set up new payor business unit. Leadership role in key partnerships. Refocused global new real-world data (RWD) and AI initiatives from long-term R&D to product development and commercialization as well.



StartX, UCSF Global Life Sciences/Healthcare Entrepreneurship Program

• Start-up Board Advisor

  • 2012 - Jul 2022

  Palo Alto, CA As a mentor in Stanford’s StartX (Med) Startup Accelerator, and UCSF, I help entrepreneurs and leadership teams of young insurtech, healthtech, AI, and data/RWE companies to address different growth hurdles. Hurdles can be related to product management, business development, cross-functional team leadership, attracting talent, pricing / business model innovation and of course fundraising.



Roche

• Switzerland
• Biotechnology Research
• 700 & Above Employee

• Director Of Global Business Development and M&A - Roche Diagnostics / Data and AI partnering

  • Jan 2019 - Oct 2021

  San Francisco Bay Area Leading partnership and M&A opportunities for (real world) data, technology, and broader scaling acceleration. Leadership role in Roche's fast-growing business unit that is pioneering a whole new SaaS platform for clinical decision AI that supports providers and patients. Driving negotiations and leading data and real-world evidence partnerships and multiple M&A projects in the US and Europe. Aligning internal and external stakeholders - across functions, geographies, and seniority… Show more Leading partnership and M&A opportunities for (real world) data, technology, and broader scaling acceleration. Leadership role in Roche's fast-growing business unit that is pioneering a whole new SaaS platform for clinical decision AI that supports providers and patients. Driving negotiations and leading data and real-world evidence partnerships and multiple M&A projects in the US and Europe. Aligning internal and external stakeholders - across functions, geographies, and seniority levels - to galvanize support for the projects to be successful pre- and post-deal signing. Leadership roles in multiple organizational change initiatives and strategic growth programs. Building out ecosystem of technology partners, including companies, institutions, startups and incubator programs in the US and abroad (incl. Israel). Show less



HealthExpense, Inc.

• Chief Executive Officer

  • Feb 2014 - Nov 2018

  Sunnyvale, CA Now part of Fidelity Netbenefits. HealthExpense pioneered an innovative, integrated B2B2C data (SaaS) and payments (%) platform for consumer healthcare payments. Resolved complex data challenges and used an 'AI-light' engagement model to improve patient engagement 10x over industry baseline. Ignited growth to exceed 30% (monthly) soon after becoming CEO. Pivoted company away from low margin/low growth business to HSA market, which was high growth/high margin. Chief… Show more Now part of Fidelity Netbenefits. HealthExpense pioneered an innovative, integrated B2B2C data (SaaS) and payments (%) platform for consumer healthcare payments. Resolved complex data challenges and used an 'AI-light' engagement model to improve patient engagement 10x over industry baseline. Ignited growth to exceed 30% (monthly) soon after becoming CEO. Pivoted company away from low margin/low growth business to HSA market, which was high growth/high margin. Chief Executive Officer 2016-2018. Chief Commercial Officer 2014-2015. Show less



Lynx Biosciences, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Advisor

  • Sep 2016 - Sep 2018

  Greater San Diego Area LynxBio is a pioneer in precision medicine with an initial focus on oncology. Its innovative technology platform has the potential to revolutionize the use of chemotherapy, as well as how oncologists make choices among many similar chemotherapy options.



Next Innovation Health Partners

• United States
• Business Consulting and Services

• President & Founder

  • Oct 2006 - 2015

  San Francisco Bay Area Clients: Fortune 500 companies, investors, and startups in healthcare innovation. For incumbents (pharma, payers, providers, software): Identify startups to invest/acquire/partner with. Develop business plans - or make strategies actionable on P&L and product level - for technology or media companies entering health markets. For startups: improving marketing/product/sales, devise business model changes, accelerate scaling, establish pilots or partnerships with right organization… Show more Clients: Fortune 500 companies, investors, and startups in healthcare innovation. For incumbents (pharma, payers, providers, software): Identify startups to invest/acquire/partner with. Develop business plans - or make strategies actionable on P&L and product level - for technology or media companies entering health markets. For startups: improving marketing/product/sales, devise business model changes, accelerate scaling, establish pilots or partnerships with right organization (pharma, insurers, tech companies entering health markets, etc.). Multiple acquisitions, pilots, partnerships or funding. Frequent speaker at conferences and corporate innovation acceleration events. Show less



Health 2.0 (acquired by HIMSS)

• President, Health 2.0 Advisors

  • 2008 - 2013

  San Francisco Bay Area I started Health 2.0 Advisors, as Health 2.0's Innovation Analytics & Acceleration business unit. Clients included Fortune 500 companies (high tech, consumer, enterprise, big pharma) such as Roche, Genentech, Xerox ACS, Abbvie, First Databank, Plantronics, Eli Lilly, and UCB. Government and non-profit clients included the White House’s healthcare innovation leadership team (ONC/HIT), Gordon and Betty Moore Foundation, and Packard Foundation. Also worked with dozens of startups (data… Show more I started Health 2.0 Advisors, as Health 2.0's Innovation Analytics & Acceleration business unit. Clients included Fortune 500 companies (high tech, consumer, enterprise, big pharma) such as Roche, Genentech, Xerox ACS, Abbvie, First Databank, Plantronics, Eli Lilly, and UCB. Government and non-profit clients included the White House’s healthcare innovation leadership team (ONC/HIT), Gordon and Betty Moore Foundation, and Packard Foundation. Also worked with dozens of startups (data analytics, fintech, insurance, benefits, payments, etc.) with game changer potential. Acquired by HIMSS.org. Show less



Affymetrix (acquired by Thermo Fisher)

• Director Strategic Marketing

  • 2005 - Sep 2006

  Santa clara, CA Affymetrix (NASDAQ:AFFX) invented the biochip and was the biochip market leader in genetics and genomics research. Acquired by Thermo Fisher Scientific for $1.3 Billion. Led multiple product and market development initiatives, incl. clinical market development in the US and Europe, new product development in cancer and pre-natal diagnostics, and was member of several task forces (e.g. Affy Labs, which was later acquired by Navigenics).



PerkinElmer

• United States
• Biotechnology Research
• 700 & Above Employee

• VP of Corporate & Business Development

  • 2002 - 2004

  Spectral Genomics revolutionized the field of cytogenetics and first-of-its-kind patient stratification capabilities to the HEM/ONC (cancer) diagnostics market, becoming the gold standard in $7.4 bil maternal and prenatal diagnostics market. Developed and executed differentiated product strategy and restructured manufacturing operations for better scaling, and build a portfolio of strategic partnerships. Structured and negotiated portfolio of >20 partnerships and licenses… Show more Spectral Genomics revolutionized the field of cytogenetics and first-of-its-kind patient stratification capabilities to the HEM/ONC (cancer) diagnostics market, becoming the gold standard in $7.4 bil maternal and prenatal diagnostics market. Developed and executed differentiated product strategy and restructured manufacturing operations for better scaling, and build a portfolio of strategic partnerships. Structured and negotiated portfolio of >20 partnerships and licenses (technology, products, distribution, etc.) with Affymetrix, Genzyme Genetics, and Labcorp. Negotiated pivotal licenses for diagnostics and research markets with Affymetrix that enabled SG to raise $9.3 Million in Series B funding. Show less



Monitor Group (acquired by Deloitte - now Monitor Deloitte)

• Principal

  • Jan 1998 - Jan 2002

  Monitor Company was founded by Michael Porter and other HBS professors and had become global strategy and investment services consulting firm with over 1,000 consultants and 30 offices worldwide. Cambridge, MA, Los Angeles, and Hong Kong-Asia offices. Worked closely with leadership teams of technology, mobile/telco, banks, info services, and pharmaceutical companies to uncover/anticipate and deliver strong new growth (revenue, profits) in new and existing markets. Clients include… Show more Monitor Company was founded by Michael Porter and other HBS professors and had become global strategy and investment services consulting firm with over 1,000 consultants and 30 offices worldwide. Cambridge, MA, Los Angeles, and Hong Kong-Asia offices. Worked closely with leadership teams of technology, mobile/telco, banks, info services, and pharmaceutical companies to uncover/anticipate and deliver strong new growth (revenue, profits) in new and existing markets. Clients include Genentech (Rituxan), AT&T, China Trust Bank, Essilor, Thomson Reuters, and World Bank. Show less



Kearney

• United States
• Business Consulting and Services
• 700 & Above Employee

• Management Consultant

  • Aug 1995 - Dec 1997

  Global management consulting firm of $1 Billion in 2005, acquired and later divested by EDS. Worked out of Benelux office and for European CEO (London). Sold $7 mil consulting project in first year.